Author

I. Gutman

Institution: University of California San Diego

Observed institution: University of California San Diego

OpenAlex ID: A5151837597

Poster: 387Evaluation of depression and anxiety symptoms after starting vanzacaftor/tezacaftor/deutivacaftor

2026 · H. D'Arrigo, I. Gutman, et al. · Journal of Cystic Fibrosis

Poster: 598Transitioning to vanzacaftor/tezacaftor/deutivacaftor: Real-world drivers and dosing strategies in a single cystic fibrosis center

2026 · I. Gutman, K. Patel, et al. · Journal of Cystic Fibrosis

Poster: 604Prescribing characteristics of asthma biologics used in an adult cystic fibrosis clinic

2026 · J. Barry, I. Gutman, et al. · Journal of Cystic Fibrosis

Poster: 603Brensocatib in cystic fibrosis: Early experience from a single center

2026 · K. Patel, I. Gutman, et al. · Journal of Cystic Fibrosis

Poster: 440Perspectives of medical providers and pharmacists regarding pharmacist contributions to cystic fibrosis outpatient care

2026 · L. Kormelink, J. Galipean, et al. · Journal of Cystic Fibrosis

Poster: 578Use of highly effective modulator therapy for non-pulmonary indications in post-lung transplant cystic fibrosis patients: Retrospective review

2026 · I. Gutman, K. Patel, et al. · Journal of Cystic Fibrosis

Works count: 6

Citation count:

H-index:

I10-index: